Edison Issues Update on International Stem Cell (ISCO) – PR Newswire (press release)
|
Edison Issues Update on International Stem Cell (ISCO)
PR Newswire (press release) International Stem Cell announced in July 2016 that it had dosed the first patient in the Phase I dose escalation study examining its neural stem cell product ISC-hpNSC for the treatment of moderate to severe Parkinson's disease. The study will enrol … |
